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ABSTRACT
Objective: Informative presence (IP) is the phenomenon whereby the presence or absence of patient data is po-
tentially informative with respect to their health condition, with informative observation (IO) being the longitudi-
nal equivalent. These phenomena predominantly exist within routinely collected healthcare data, in which data
collection is driven by the clinical requirements of patients and clinicians. The extent to which IP and IO are con-
sidered when using such data to develop clinical prediction models (CPMs) is unknown, as is the existing meth-
odology aiming at handling these issues. This review aims to synthesize such existing methodology, thereby
helping identify an agenda for future methodological work.
Materials and Methods: A systematic literature search was conducted by 2 independent reviewers using pre-
specified keywords.
Results: Thirty-six articles were included. We categorized the methods presented within as derived predictors
(including some representation of the measurement process as a predictor in the model), modeling under IP,
and latent structures. Including missing indicators or summary measures as predictors is the most commonly
presented approach amongst the included studies (24 of 36 articles).
Discussion: This is the first review to collate the literature in this area under a prediction framework. A consider-
able body relevant of literature exists, and we present ways in which the described methods could be devel-
oped further. Guidance is required for specifying the conditions under which each method should be used to
enable applied prediction modelers to use these methods.
Conclusions: A growing recognition of IP and IO exists within the literature, and methodology is increasingly
becoming available to leverage these phenomena for prediction purposes. IP and IO should be approached dif-
ferently in a prediction context than when the primary goal is explanation. The work included in this review has
demonstrated theoretical and empirical benefits of incorporating IP and IO, and therefore we recommend that
applied health researchers consider incorporating these methods in their work.
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Clinical prediction models (CPMs) estimate the risk that a patient
currently has (diagnostic), or will develop (prognostic), an outcome
of interest based on known clinical and patient measures. Such risk
models can guide clinical decision making, among other uses.
Widespread adoption of electronic health records (EHRs) facili-
tates the development of CPMs,1 as detailed clinical and patient in-
formation is collected through routine healthcare contacts. Such rich
longitudinal information provides long-term patient follow-up with-
out the need to recruit patients and conduct regular follow-up visits.
The analysis of routinely collected data is not, however, without
challenge. Observation times are not prespecified as they would be
in a typical research study (eg, in a prospective cohort study with
scheduled follow-up visits). Instead, data are collected opportunisti-
cally, in which patient and clinician decisions directly dictate
whether we observe clinical biomarkers and patient information.2
For example, general practitioner visits occur more frequently dur-
ing periods of ill health,3 and only information relevant to the par-
ticular consultation will be recorded. Equally, during inpatient care,
clinicians will adapt their monitoring frequency to the changing
needs and condition of the individual patient (see Figure 1).
We refer to the process by which visits, and hence measurements,
occur as the observation process (also known elsewhere as the visit-
ing or monitoring process). We define 2 key properties that an ob-
servation process may have, when presence of data is informative:
1. Informative presence (IP) (Figure 1A): The presence or absence of
a patient’s data at any given time point carries information about
their health status.
2. Informative observation (IO): The timing, frequency, or intensity
(rate) of a patient’s longitudinal pattern of observation carries in-
formation about their evolving health state. See Figure 1B for an
example.
IP is challenging from a statistical perspective as it implies a miss-
ing not at random process. IP is, however, conceptually different
from missingness, as in the former, there was never any intention of
collecting the data at a particular visit. IP has previously been de-
fined elsewhere,5,6 with Phelan et al5 discussing how interactions
contained within EHRs are informative with respect to patient
health.
IO is the continuous time generalization of IP: a longitudinal vis-
iting (at time t) not at random process, defined as “given data
recorded up to time t, visiting at time t is not independent of out-
come at time t.”7 By generalizing the definition of IP above, one can
draw value from how frequently a patient is observed over time.
This is especially true when no schedule exists dictating when or
how often visits should occur; we therefore focus on what an indi-
vidual’s longitudinal observation process could tell us about their
condition.
A recent review of CPMs developed using routinely collected
data revealed an apparent lack of understanding of, or proper han-
dling of, IP and IO.1 Moreover, much of the existing methodological
literature in this area has focused on IP and IO only in the context of
effect estimation (ie, in causal or associational studies),8–14 and has
generally viewed it as a “nuisance” (ie, a phenomenon that poten-
tially biases effect estimators and therefore needs to be corrected for
in the analysis). However, when developing a CPM, the primary fo-
cus is on achieving good predictive performance; predictor effect es-
timation is less important.
Instead, one could view IP and IO as opportunities to draw infor-
mation from the EHR that is not explicitly recorded. In this article,
we focus on informative measurement patterns in the predictors,
and we do not discuss presence or absence of outcome data. Agniel
et al15 demonstrated how the timing of a lab test better predicts
mortality than the actual result of the test. Others have illustrated
how incorporating the presence or absence of a particular test for an
individual into a CPM can improve its accuracy.16–18
Objectives
This article aims to review the literature on methodology allowing
CPMs to utilize IP or IO, both in overcoming some of the aforemen-
tioned challenges, and in harnessing information within informative
measurement patterns. In doing so, we also highlight outstanding
areas of methodological work that should be prioritized. Finally, we
summarize existing software packages capable of implementing the
methodology.
MATERIALS AND METHODS
The strategy employed in this review loosely follows a scoping re-
view framework.19 Our protocol has been registered on the Open
Science Framework.20
Search strategy
We searched MEDLINE, Embase, and Web of Science for relevant
articles using prespecified search terms. Further details of the full
search strategy (including search terms and an additional snowball-
ing stage) can be found in the Supplementary Appendix and the pub-
lished protocol.20
Study selection
We had the following inclusion criteria: any article presenting a
method that allows CPMs to incorporate IP or IO. We excluded
articles that applied existing methods that had already been pub-
lished elsewhere, and included those earlier publications instead,
nonmedical areas of application, IP and IO in outcome measures,
and methods that handle sample selection bias, imputation or cen-
soring only. See the Supplementary Appendix for further justifica-
tion of these exclusions.
We do not include textbooks within the review; while this could
mean we miss some relevant literature, searching within textbooks
is not widely feasible. Additionally, we believe that most methodo-
logical development in this area will be published in original re-
search articles rather than textbooks.
Two independent reviewers (R.S., L.L.) conducted a 2-stage
screening process. Titles and abstracts were screened first, and full
texts of remaining articles were reviewed at the second stage.
Reviewers met regularly to track agreement. Systematic differences
were translated into new inclusion and exclusion criteria, in consul-
tation with a third reviewer (G.P.M.).
Primarily, we extracted information regarding the modeling
method employed and any reported advantages and disadvantages.
We also extracted information on the form of the observation
processes, predictors, and outcome, including any clinical use cases
presented.
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Figure 1. (A) An illustration of informative presence and how this could impact the information available at prediction time. We see the longitudinal pattern of blood
pressure for 2 patients, with both their observed and unobserved values shown. Patient 1 has 1 single observed value of systolic blood pressure (BP), and this hap-
pens when their BP was at its highest. Patient 2 has no observed values, but their BP remains in the normal range—either the patient or clinician saw no clinical
need to take a blood pressure measurement at any time. (B) An illustration of informative observation, taken from the MIMIC (Medical Information Mart for Inten-
sive Care) dataset.4 Patient 1 has many more in-hospital measurements of blood glucose than patient 2 throughout their intensive care unit admission, likely due to
the fact that their blood glucose is much higher and much more variable than patient 2. A more severe condition often means more intense monitoring.












Our database searches identified 6127 studies, of which 111 were
retained for full text screening. Eleven of these were deemed eligible
for inclusion. We identified a further 25 articles through forward
and backward citation searching, giving a final set of 36 included
articles (Figure 2).
Throughout this section, we will illustrate each method with the
following notation. Consider a binary outcome Y tð Þ (or Y if only
observed once) for patients i ¼ 1; . . . ; n, at time t, where Y ¼ 1
denotes that the event occurred, with marginal probability P Y ¼ 1½ .
Define a potentially time-varying continuous covariate process XðtÞ,
with potential realizations xij for i ¼ 1; . . . ; n and j ¼ 1; . . . mi, or
simply xi if X is not time-varying. The timing of the j
th realization of
X tð Þ is tij 2 Rþ. Denote R ¼ 1 if X tð Þ is ever observed, and
R ¼ 0 if not. Define rij ¼ 1 if the covariate process is observed at
time tij. We assume that Z is a completely observed time-invariant
covariate. gð:Þ represents a link function (eg, the logit function).
Broadly, the methods in this article cover the 3 scenarios de-
scribed in Table 1. To illustrate the prediction scenarios and meth-
ods, we consider a simplified version of the Sequential Organ
Failure Assessment score,21 used to predict mortality in critical care,
assuming that the only predictors in the model are bilirubin and
blood pressure. Of these 2 predictors, we assume that blood pressure
is completely observed for all patients, and that bilirubin is informa-
tively observed, as it has been shown to be within critical care.
Depending on the specific scenario, it may be a one-time point ob-
servation, or a longitudinal process.17
There exists a breadth of methodological literature covering sce-
nario 2 (S2) (without accounting for IP and IO), which has recently
been synthesized by Bull et al.22 We therefore focus on modeling
strategies that have specifically been proposed or extended to ac-
commodate IP or IO.
Identified approaches to handle IP and IO
We identified 3 broad categories of method based on the included
articles: (1) methods that incorporate IP or IO through derived pre-
dictors; (2) methods for modeling under IP; and (3) methods that in-
corporate IP or IO using latent structures. Within these 3 categories,
we identified 8 modeling strategies. A summary of the methods can
be found in Table 2. Table 3 summarizes the advantages, disadvan-
tages, software, and assumptions for each method—here, the
reported advantages and disadvantages were inferred by the research
team because they are not consistently mentioned in the included lit-
erature. A summary table at article level can be found in Supplemen-
tary Appendix 3.
Category 1: Derived predictors
The methods described in this section address IP or IO by deriving
some representation of the observation process and including this as
a separate predictor in the model to exploit the informativeness for
predictive value. These approaches tend to be straightforward and
have been proposed to handle both IP and IO. However, attention
must be paid to the intended use of the final model, particularly
where the model will be applied in clinical settings different to the
one in which it was developed. Where measurement protocols
change across different settings, these models may lack generaliz-
ability when transported to a new setting.57–59 This should not be a
concern where the development and application settings remain the
same.
Missing indicators or separate class
The missing indicator approach16,23–30 handles IP in a straightfor-
ward manner, by deriving a binary variable that indicates whether a
predictor has been observed at a specific time (IP) or over a defined
window of time. The indicators enter the prediction model as a
separate predictor alongside other patient and clinical information.
Figure 2. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram showing the various screening stages and reasons for ex-
clusion at each stage.
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For example, if a prediction model requires an entry for bilirubin
but this test has not been conducted, then a missing indicator would
be included as a predictor with value 1 (or 0 when observed).
For categorical variables, a separate “missing” category could in-
stead be created.
Because most prediction models require a value for every predic-
tor, the missing indicator approach is usually combined with impu-
tation at both model development and prediction time (not
necessary for categorical predictors with a separate class).The miss-
ing indicator approach results in a model of the form:
g P½Y ¼ 1jX; Zð Þ ¼ b0 þ b1Xþ b2Zþ cR (1)
for continuous predictors within cross-sectional prediction (S1).
Similarly, for a categorical predictor xi with k categories, then
the missing indicator approach would set xi 2 f
Cat1; . . . ; Catk; Missingg and our model would be
g P½Y ¼ 1jX; Zð Þ ¼ b0 þ b1Xþ b2Z (2)
The previous 2 equations could be combined to consider predic-
tion models with both continuous and categorical predictors. Alter-
natively, missing indicators and separate classes have been well
developed in tree-based prediction algorithms.28–30
Including a missing indicator or separate class is straightforward
and has demonstrated improved predictive performance over models
omitting them.17 However, their inclusion could double the number
of candidate predictors for a model. The approach also fails to cap-
ture complex representations of the measurement process.
Summary measures
An extension to missing indicators, capable of incorporating both IP
and IO, is to derive a summary of the measurement process and in-
clude this as a predictor.15,24,31–44 Examples include a count of the
number of measurements (eg, throughout a critical care admis-
sion),37 weighted counts,42 combined missing indicators,31 missing-
ness rates over time,32 time intervals between measures,33–35
embedding vectors that represent missing values,36 or information
relating to hospital processes.38,39
In some cases, combined missing indicators and time intervals
also alter the relationship between a predictor and outcome. Che
et al’s24 method stipulates that the longer a measure has been miss-
ing, the less influence it should have on an individual’s prediction;
therefore, the last observed measurement is decayed toward a mean
value.
Piecewise-constant intensity models have also been proposed to
handle informatively observed predictors.40,41 Piecewise-constant
intensity models use decision trees to assign an intensity rate to the
observation process, conditional on its history (timings, values, and
events).
Define a summary measure of the observation process Q, eg, a
count of the number of times XðtÞ (whether continuous or categori-
cal) has been observed: Q ¼ mi. For cross-sectional prediction with
a time-varying covariate, we then have:
g P½Y ¼ 1jX; Zð Þ ¼ b0 þ b1Xþ b2Zþ cQ (3)
where X is a summary of XðtÞ deemed to have predictive value (eg,
the mean, most recent, or most extreme value). If XðtÞ has never
been observed, this should be imputed. Like missing indicators,
summary measures are easily derived and implemented in any pre-
diction model using standard software (since they are included as
standard predictors). Combining missing indicators into one sum-
mary, or implementing a dimension-reduction technique such as
Lasso, also overcomes the issue of including multiple missing indi-
cators. However, selecting the most appropriate summary measure
for a model requires careful consideration, and will depend on the
clinical application. No current guidance exists on how best to
choose the most appropriate summary measure. The association
between a chosen summary measure and the outcome might lack
generalizability where measurement processes vary across loca-
tions.23,39 Simple summary measures such as counts may also fail
to capture the complex relationship between the observation pro-
cess and outcome.
Category 2: Modeling under IP
While the methods in the other categories can be used to handle
both IP and IO, this category comprises methods that have specifi-
cally been proposed to handle IP.
Pattern-specific models
The pattern-specific approach45,46 derives separate models for each
missingness pattern, generalizing the missing indicator approach.
The model corresponding to the observed pattern in a new individ-
ual is then used for prediction. For example, in a model with a single
partially-observed time-invariant continuous predictor, X we would
derive the following submodels:
g P Y ¼ 1jR ¼ 1; X; Z½ ð Þ ¼ b0;1 þ b1;1Xþ b2;1Z (4)
Table 1. A description of different prediction scenarios, covering cross-sectional vs longitudinal predictors and outcomes
Scenario Scenario name Description Example (SOFA)
S1 Cross-sectional prediction Interest lies in obtaining a single prog-
nostic estimate (prediction) using a
single value for each predictor.
Use values of bilirubin and BP obtained
upon ICU admission to predict in-hos-
pital survival (binary).
S2 Cross-sectional prediction with
longitudinal predictor measure-
ments
Interest lies in obtaining a single prog-
nostic estimate but using the longi-
tudinal history of predictor values.
Use all repeated lab tests obtained
throughout inpatient admission for bil-
irubin and BP to predict in-hospital
survival.
S3 Longitudinal prediction with longi-
tudinal predictors and outcomes
Interested in prognostic estimates at
multiple time points, potentially us-
ing the longitudinal history of pre-
dictor values.
Use all repeated measures of BP and bili-
rubin obtained throughout inpatient
and ICU admission to predict survival
at multiple future time points.
BP: blood pressure; ICU: intensive care unit; S: scenario; SOFA: Sequential Organ Failure Assessment;
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g P Y ¼ 1 jR ¼ 0; Z½ ð Þ ¼ b0;2 þ b2;2 Z (5)
Where Z is completely observed. Note that formulas 4 and 5 can
also be combined by including interaction terms with the missing in-
dicator, illustrating how this approach extends the missing indicator
method.
Similar submodels could be derived for categorical and continu-
ous predictors. Saar-Tsechansky and Provost45 proposed using all
available data to train each submodel, whereas Fletcher et al46 rec-
ommended that only individuals in each observed pattern be used in
the derivation of that pattern’s submodel (also illustrated by Janssen
et al).60 The latter approach does not require knowledge of the miss-
ingness mechanism.
The pattern-specific approach is flexible, as it can be applied to
any form of prediction algorithm. However, a practical limitation is
that the number of candidate submodels becomes intractable as the
number of predictors increases.
Likelihood-based methods
A different approach assumes that missingness in the predictors is
nonignorable, and incorporates this into parameter estimates via
likelihood-based methods.47,48 The model formulation would take,
for example, the same form as equation 2, with parameter estimates
obtained according to estimation procedures detailed in the following
examples. Escarela et al47 assumed a bivariate copula-based probabil-
ity function for the missing covariates and the missingness mechanism.
Kirkham48 instead applied the “method of weights,” which assumes a
parametric model for the missingness mechanism and incorporates
this into the maximum likelihood estimation of parameter estimates.
Table 3. Summary of (subjective assessments of) advantages, disadvantages, software, and assumptions for each method described in this
review
Modeling approach Advantages Disadvantages Software Assumptions






Potentially doubles no. of
predictors
Too simplistic for complex
relationships between
missingness and outcome
Assumes discrete time inter-
vals
Easily applied in common
statistical software
Assumes absence is a proxy









across centers may be
questioned




Easily applied in common
statistical software
Assumes observation pro-
cess is a proxy for some
unmeasured patient fea-
ture




Number of models becomes
large as no. of predictors
increases
Easily applied in common
statistical software
No assumptions placed on
how missingness relates
to observed or unob-
served variables
Assumes same functional
form for all pattern-spe-
cific models
Likelihood-based methods Also allows for imputation Computationally intensive None provided Assumes absence is related
to the unobserved value
Similarity measures Flexible Computationally intensive None provided None provided
Latent variable Improved performance over
methods not incorporat-
ing informative presence







HMMs Using a Hawkes process for




None provided Assumes longitudinal pre-




Flexible to different forms
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HMM: hidden Markov model.
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Escarela et al47 described how their missing not at random model
can also be used to impute missing values. However, this does not
remove the need to make untestable assumptions on the missing
data mechanism.
Category 3: Latent structures
Similarity measures
Patient similarity measures apply a sequencing algorithm to estab-
lish the alignment of 2 sequences of patient data (eg, longitudinal
EHR data). Sha et al49 presented a novel similarity measure, which
recognizes that the type of tests ordered and the time between tests
can be indicative of patient condition. Their metric is therefore
based on a distance measure incorporating the type, timings and
results of tests and they assume that more intense monitoring indi-
cates a more severe condition.
The sequencing algorithm produces a similarity matrix, defining
the similarity between each pair of patients. We do not present the
model formulation for this method since there are various
approaches to using this matrix in prediction (described by Shara-
foddini et al.)61 One such method defines cohorts of “similar”
patients within which to develop separate models. This approach
can be viewed as an extension of the pattern submodel approach
with longitudinally and irregularly measured predictors, in which
the patterns are defined by similar longitudinal sequences.
The benefit of this method is that, as with others, it can be ap-
plied to any form of prediction framework. Drawbacks include the
computational burden of rederiving multiple models, and requiring
access to the training data at prediction time to train a model using
similar patients.
Latent variable
A simple way of representing a latent clinical condition is to use a
single (partially) latent binary variable, representing 1 of 2 states.
This approach was used by Coley et al50 and Hubbard et al51 in
which IP and IO are incorporated by allowing the measurement pro-
cess to infer a latent patient condition under a hierarchical structure.
Define the partially latent binary outcome YL  BernðgÞ rep-
resenting 1 of 2 patient states, where only 1 state is entirely ob-
served. In Coley et al50’s example, “true” cancer state (aggressive vs
indolent) is the outcome, but is only observed for a subset of patients
who underwent surgery. We then assume that the value of the out-
come can influence the presence of xi within the hierarchical model.
R YL; Z  Bern P R ¼ 1 YL; Z; b
  
(6)
We have not provided the outcome model formulation since pre-
dictions are obtained by sampling from the posterior of the full hier-
archical model.
Both studies note improved predictive performance in which the
measurement process influences predictions compared with a model
that ignores IP and IO. These models can, however, be computation-
ally intensive to fit.
Hidden Markov models
Hidden Markov models extend the latent variable approach by
allowing a time-varying latent process. Zheng et al52 and Alaa et
al53 used hidden Markov models to capture IO, but the way they in-
corporated the observation process differs. Hidden Markov model–
based prediction models incorporate IO by allowing the measure-
ment frequency or rate to infer the clinical state at any given time.
Alaa et al53 proposed a latent semi-Markov process to capture a
patient’s evolving clinical state. The “state” variable,
YL tð Þ 2 f1; . . . ; 4g, ranges from clinical stability to clinical deteri-
oration, where stability (state 1) and deterioration (state 4) are ob-
served states, but intermittent states are latent. Here the model aims
to predict eventual clinical deterioration, that is, P½Y 1ð Þ ¼ 4. The
observation process (ie, timings) of XðtÞ is used to infer this clinical
state, in which it is assumed that increased monitoring indicates a
less stable condition. A marked point process model (in this case a
Hawkes process) is adopted to model the rate of patient monitoring,
with the marks corresponding to the observed value. IO is captured
through state-specific intensity functions for the monitoring fre-
quency as follows:
kðt YLðtÞ ¼ 1Þ ¼ k1 þ a1
X
s< tm < t
eb1 ttmð Þ (7)
. . .
kðt YLðtÞ ¼ 4Þ ¼ k4 þ a4
X
s< tm < t
eb4 ttmð Þ (8)
k1; . . . ; k4; a1; . . . ; a4; b1; . . . ; b4 are state-specific parameters to
be estimated. tm is the time of the last measure of XðtÞ. s is the time
of the most recent change in YLðtÞ, which is only observed if the
state is absorbing. Details of the learning and prediction algorithm
are presented in more detail in their article.
A key advantage is that the Hawkes process allows for a time-
varying intensity in the observation process. Model fitting and inter-
pretation are, however, complex because there are multiple compo-
nents to be estimated simultaneously.
Joint modeling
Joint modeling has been developed extensively within the prediction
context, particularly for dynamic prediction, that is, incorporating
time-updated variables (S2 in Table 1).62–65 Joint modeling can be
extended to handling IP and IO, by linking the outcome to the ob-
servation process via a shared random effect,54–56 which can be seen
as an alternative approach to modeling latent variables. Separate
models are defined for the outcome occurrence and the observation
process, each of them containing an individual-level random effect
representing individual “frailty.” By sharing these random effects
across the 2 models, the outcome and observation processes are
linked. Liang et al54 and Choi et al56 both allow for irregularly ob-
served visits, and therefore specify a hazard or intensity function
that defines how often visits occur. The random effect, or frailty
term, controls how an individual’s visit rate differs from average. As
this effect also appears in the model for the outcome, the visit rate
indirectly affects the prediction for the outcome.
The method outlined in Zhang et al55 only allows for scheduled,
regular observations. Therefore, rather than specifying a model for
the intensity/hazard of visiting, the “observation process” model is a
repeated measures logistic regression model, in which the outcome
indicates whether an individual provided data at a specific time point.
Joint models take many different forms and provide the most
general framework. We present an example of a trivariate joint
model, with submodels for the repeatedly and informatively
measured covariate, the binary outcome, and the observation pro-
cess of the covariate xij. Assuming that measurement times are
regular (, tij ¼ tj 8 i; j).
X ¼ a0 þ a1Zþ a2t þ U (9)
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g P½Y ¼ 1jZ; U; Vð Þ ¼ b1Zþ b2U þ b3V (10)
h P Rj ¼ 1jU; V; Z
  
¼ d0U þ V þ d1Rj1 þ d2Z (11)
Here, U and V are independent subject-specific random
effects, and g :ð Þ and hð:Þ are link functions. b2 and d1 control the
relationships between the longitudinal predictor and the outcome,
and the longitudinal predictor and the observation process, respec-
tively. b3 controls the association between the outcome and the
missingness process. Missingness at time t depends on missingness at
the previous measurement time.
The listed examples illustrate the flexibility of joint modeling, as
the models for both the observation outcome processes can take dif-
ferent functional forms. Complex dependencies between the pro-
cesses can be specified. However, fitting these models can be
computationally intensive, and the interpretation of random effects
in a prediction model can be challenging, especially for end users.54
DISCUSSION
This study has identified 3 broad categories of approaches to incor-
porate IP or IO into clinical prediction models: derived predictors,
modeling under informed presence, and latent structures. This is a
growing area of research, and much of the included literature illus-
trates that IP and IO can be incorporated into clinical prediction
models in a meaningful way. Where missing data and nonrandom
visit processes have been seen as a nuisance in effect estimation, a
more positive outlook is possible when the goal is prediction. Al-
though methodology allowing CPMs to accommodate IP and IO are
emerging, further challenges remain, which will be discussed later.
Pullenayegum and Lim7 and Neuhaus et al9 have previously
reviewed methods for handling IO in studies in which the primary
aim is to recover unbiased effect estimates. Both articles assume that
the outcome is informatively observed, which differs from the focus
of our work in which we assume informatively measured predictors.
Phelan et al5 presented a set of design considerations for EHR-based
studies that could help to attenuate issues caused by IP and IO by
carefully considering and defining the population of interest (eg, in
which part of the care system patient interactions occur) and how
health status could affect patient interactions. None of these articles
explicitly discuss prediction, in which we anticipate that the most
appropriate methods will differ from those for effect estimation.
Empirical studies37,66 have compared methods capable of han-
dling repeatedly measured predictors in CPMs, and many of these
methods can be extended to accommodate IO, such as summarizing
the process into a single measure (eg, the mean or maximum mea-
surement patterns as predictors) or into more complex latent process
methods. Both studies found that joint modeling provided little ben-
efit in predictive performance when compared with simple summary
measures, but care should be taken in selecting an appropriate sum-
mary measure suited to the clinical context. Bull et al22 also recom-
mended 3 key considerations when choosing the most suitable
method for harnessing a longitudinally measured predictor: the type
and amount of information available at prediction time, how the
CPM can benefit from the longitudinal information and the validity
of assumptions for the particular application. We expect that these
considerations will also be relevant to selecting the most appropriate
means of incorporating IO.
To our knowledge, this is the first attempt at synthesizing the
methodology available to handle IP and IO specifically for predic-
tion purposes. We have achieved this through a systematic search of
the literature. A potential limitation is that only the health and bio-
medical literature was considered; as such, our search potentially
did not capture methods that have been developed for use in other
fields. Defining relevant terminology around IP and IO is challeng-
ing, as the nomenclature differs across the literature. This is illus-
trated by the fact that a minority (n ¼ 11 of 36) of included articles
were discovered directly through database searches. However, this is
a common challenge with methodological reviews.67,68 It is possible
that methods were missed as a result, but we aimed to mitigate
against this by conducting a backward and forward citation search
on articles identified through the search strategy and on a set identi-
fied as relevant a priori.
Many of the methods discussed herein remain underdeveloped
and future studies should investigate the degree to which these meth-
odological choices matter for prediction contexts. We have identi-
fied multiple avenues for further research. Missing indicators,
capable of handling both IP and IO, is the most common approach
(in terms of number of studies included) to incorporating the obser-
vation process. Although this method is straightforward and adapt-
able to any type of prediction model, key challenges remain,
including but not limited to the requirement to impute missing val-
ues when developing and applying the model. Under most prediction
frameworks, a value must be entered for any predictor in the model
when a prediction is made. The impact of using different imputation
techniques at model development and prediction time should be
established.
Pattern-specific models present a promising extension to the
missing indicator approach, and do not require imputation at either
model development or application. Further development should ex-
plore ways to borrow strength across models, or pool together sets
of patterns, to overcome the issue of developing models with few
data points for rarely observed missingness patterns.
Most methods capable of handling IO fall under the “summary
measures” category (16 articles). The simplicity of this approach is
attractive but is also a concern. Simple summaries of the entire pro-
cess do not capture important changes in the observation process
over time, such as a sudden increase in monitoring frequency which
indicates worsening state. Latent structure approaches (eg, modeling
measurement times via a nonhomogeneous point process) may be
better suited to capturing longitudinal variability but are computa-
tionally intensive. Developing a more sophisticated representation
of the observation process to use as a predictor is a promising ave-
nue of further research, offering a potential trade-off between the
simplicity of summary measures and the sophistication of joint
modeling. These more complex measures should be compared with
both joint modeling techniques and simple summary measures to as-
sess their added benefit in terms of predictive performance and com-
putational efficiency. We plan to perform such comparisons in a
separate full empirical study.
There already exists a vast body of literature on joint modeling
for prediction, particularly covering S2 (incorporating longitudinal
predictors). Such methods have also recently been extended to func-
tional data,69 allowing them to accommodate complex structures in
longitudinal predictors. Joint models have also been proposed to
handle IO under an inferential framework,8,9,70,71 so it follows that
there is scope to extend joint models further to exploit IO for predic-
tive benefit, as this review revealed that the method remains under-
developed for this particular purpose.
There are broader challenges associated with exploiting IP and
IO for prediction. First, because the association between the obser-
vation process and outcome is unlikely to be causal, this relationship
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may not generalize well to different settings. For example, clinicians’
monitoring behaviors are likely to vary across units or clinical guide-
lines could recommend changes in the way patients are observed.
This is particularly true following the introduction of a CPM into
clinical practice; once this happens, the predictor variables in the
model are far more likely to be observed. The predictive utility of
any model incorporating the observation process should therefore
be regularly validated and potentially updated.
A second challenge described by Alaa et al53 concerns models
that use the observation process to inform predictions, but also up-
date predictions as new information becomes available. An issue
arises when clinicians change their monitoring behavior based on
predictions produced by the model; any changes in the way they
monitor patients will be fed back into future predictions via the ob-
servation process. This should be accounted for to avoid the feed-
back loop, potentially by developing causal models to account for
the possible time-varying confounding,72 or by explicitly modeling
the effects of previous predicted values.
Despite these challenges, we view IP and IO as opportunities to
improve the performance of predictive models, as opposed to a nui-
sance. The literature is divided on this point; much of the work in
this review proposes methods that “overcome” the challenges of IP
and IO, whereas others illustrate the added benefit of incorporating
informative measurement patterns. Missing data have typically been
seen as a threat to the estimation of parameters, but because this is
not the key focus of prediction research, it may be useful to move
away from terms such as missingness and instead focus on what the
presence of an observation can tell us.
CONCLUSION
We have demonstrated that there is a growing recognition of both IP
and IO within prediction research. Although parallels exist with
missing data, IP should not be considered the same way, especially
within the context of prediction and routinely collected data in
which there is no prespecified observation process. By synthesizing
the available methods and software that could be applied to incor-
porate IO and IP into CPMs, this article can assist applied research-
ers in adopting suitable methods. Future research should investigate
the challenges presented herein, which will require the development
of formal guidelines and making existing methodology more
accessible.
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